SAHPRA Approves Lenacapavir For HIV Prevention
SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expected by April 2026.
In other news, communities face various challenges, including limited access to mental health care, with nine out of 10 young people exposed to violence and trauma having little to no access.
Additionally, issues with healthcare and water delivery persist, with reports of a woman being asked to walk to the labour ward while in advanced labour, and water being delivered to a communal tank only three times a week.
No direct quotes available.
Author's summary: SAHPRA approves lenacapavir for HIV prevention rollout.